ホーム > 組織・各部の紹介 > データサイエンス部 > 業績

データサイエンス部

論文

  • Huang WS, Hung NH, Hamasaki T, Hsiao CF. Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints. PLoS ONE 12, e0180405, 2017.
  • Asakura K, Hamasaki T, Evans SR. Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints. Biometrical Journal 59, 703-731, 2017.
  • Sugimoto T, Hamasaki T, Evans SR, Sozu T. Sizing clinical trials when comparing bivariate time-to-event outcomes. Statistics in Medicine 36, 1363-1382, 2017.
  • Ochiai T, Hamasaki T, Evans SR, Asakura K, Ohno Y. Group-sequential three-arm noninferiority clinical trial designs. Journal of Biopharmaceutical Statistics 27:1-24, 2017.
  • Sozu T, Sugimoto T, Hamasaki T. Reducing unnecessary measurements in clinical trials with multiple primary endpoints. Journal of Biopharmaceutical Statistics, 26:631-643, 2016.

総説・解説

  • 濱﨑俊光. 統計家からの一言:仮説検定におけるp値の解釈. Coronary Intervention 13(2), 59-62, 2017.
  • 朝倉こう子・濱﨑俊光. 回帰解析: ロジスティック解析を中心として. Drug Delivery System 31, 72-81, 2016.

書籍

  • Hamasaki T, Asakura K, Ochiai T, Evans SR. Group-Sequential Clinical Trials with Multiple Co-Objectives. Cham/Heidelberg/New York: Springer, 2016.

その他の出版物

  • Hamasaki T, Evans SR. Interview with Professor Geert Molenberghs. CHANCE 30, 16-23, 2017.

学会発表

  • Dimairo M, Todd S, Julious S, Jaki T, Wason J, Hind D, Mander A, Wier C, Koenig F, Altman D, Nicholl J, Hamasaki T, Proschan M, Scott J, Walton M, Ando Y, Biggs K, Pallmann P, Coates E, on behalf of the ACE project Steering Group. Journeying through the development of an adaptive designs reporting guidance: preliminary findings. Joint Conference on Biometrics & Biopharmaceutical Statistics (CEN-ISBS Vienna 2017), Vienna, Austria, August 28 - 1 September 1, 2017.
  • Hamasaki T, Evans SR, Asakura K. Design, data monitoring and analysis of clinical trials with co-primary endpoints. Joint Conference on Biometrics & Biopharmaceutical Statistics (CEN-ISBS Vienna 2017), Vienna, Austria, August 28 - 1 September 1, 2017. (Invited Presentation)
  • Asakura K, Hamasaki T, Evans SR, Interim evaluation of futility in clinical trials with co-primary endpoints. Joint Conference on Biometrics & Biopharmaceutical Statistics (CEN-ISBS Vienna 2017), Vienna, Austria, August 28 - 1 September 1, 2017. (Topic-contributed Presentation)
  • Hamasaki T, Evans SR, Sugimoto T, Asakura K. Designing complex survival clinical trials with multi-stage and multiple endpoints. Joint Statistical Meetings 2017, Baltimore, July 29 - August 3, 2017. (Topic-Contributed Presentation).
  • Hamasaki T, Evans SR, Sugimoto T, Asakura K. Statistical monitoring of clinical trials with semi competing risks outcomes. The 2017 ICSA Applied Statistics Symposium, Chicago, Illinoi, June 25-28, 2017. (Invited Presentation).
  • Hamasaki T, Evans SR, Sugimoto T, Asakura K. Group-sequential designs in clinical trials with semi competing risks outcomes. The 10th International Conference on Multiple Comparison Procedure, Riverside, California, USA, June 20-23, 2017.
  • Dimairo M, Todd S, Julious S, Jaki T, Wason J, Hind D, Mander A, Wier C, König F, Altman D, Nicholl J, Hamasaki T, Proschan M, Scott J, Walton M, Ando Y, Biggs K, Pallmann P, Coates E, on behalf of the ACE project Steering Group. Journeying through the development of an adaptive designs reporting guidance: preliminary findings. Evidence Live 2017 Conference, Oxford, UK, June 21-22, 2017.
  • Hamasaki T, Asakura K, Sugimoto T, Evans SR, Hsiao, CF, Yamamoto H. Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials. The 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials, Liverpool, UK, May 7-10, 2017.
  • Hamasaki T, Yamamoto H, Tanaka S, Sato ST. A Program for Training the Next Generation of Biostatisticians in Japan: Developing On-the-Job Training at NCVC. The 4th International Clinical Trials Methodology Conference (ICTMC) and the 38th Annual Meeting of the Society for Clinical Trials, Liverpool, UK, May 7-10, 2017
  • Hamasaki T. Integrated e-Clinical solution: Experiences from Japan. DIA China Seminar (Application of Information Technology in Clinical Research), Shanghai, China, April 20-21, 2017 (Invited Presentation).
  • Hamasaki T, Evans SR, Sugimoto T, Asakura K. Statistical monitoring of clinical trials with semi-competing risks outcomes. ENAR 2017 Spring Meeting, Washington, DC, USA, March 12-15, 2017.
  • Hamasaki T. Interim evaluation of efficacy or futility in group-sequential clinical trials with multiple co-primary endpoints. The 10th International Chinese Statistical Association International Conference, Shanghai, China, December 19-22, 2016. (Invited Presentation)
  • Hamasaki T. Improving the Quality of Clinical Trials in Network for Clinical Stroke Trials. New Trends in Clinical Trials, Taipei, Taiwan, November 23, 2016. (Invited Presentation)
  • Hamasaki T. Statistical monitoring of clinical trials with two event-time outcomes. Graduate Institute of Statistics, National Central University, Taipei, Taiwan, November 22, 2016. (Invited Presentation)
  • Hamasaki T, Sugimoto T, Asakura K, Evans SR. Early evaluation of efficacy in group-sequential clinical trials with two time-to-event outcome. The 2016 ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop. Washington, DC. USA, September 28-30, 2016. (Poster Competition Winner).
  • Hamasaki T. Improved group sequential clinical trial designs when comparing two interventions using two time-event outcomes. The 2016 International Indian Statistical Association Conference on Statistics, Corvaliis, Oregon, USA, August 18-21, 2016. (Invited Presentation)
  • Hamasaki T, Sugimoto T, Asakura K, Evans SR. Group-sequential clinical trials for comparing two interventions using two time-to-event outcomes. Joint Statistical Meetings 2016, Chicago, USA, July 30 - August 4, 2016.
  • Asakura K, Hamasaki T, Koenig F, Posch M. Improved group sequential clinical trial designs with multiple co-primary endpoints. Joint Statistical Meetings 2016, Chicago, USA, July 30 - August 4, 2016.
  • Hamasaki T. Interim evaluation of efficacy or futility in group-sequential trials with multiple co-primary endpoints. The 25th South Taiwan Statistics Conference, National Sun Yat-sen University, Kaohsiung, Taiwan, R.O.C., June 24-25, 2016. (Invited Presentation)
  • Hamasaki T, Ochiai T, Evans SR, Asakura K, Fukuda M, Yamamoto H. Group-sequential three-arm noninferiority clinical trial designs. The 37th Annual Meeting of the Society for Clinical Trials, Montreal, Quebec, Canada, May 15-18, 2016.
  • Asakura K, Hamasaki T, Evans SR, Hsiao CF, Fukuda M, Yamamoto H. Interim monitoring of clinical trials with co-primary endpoints using predicted intervals. The 37th Annual Meeting of the Society for Clinical Trials Montreal, Quebec, Canada, May 15-18, 2016.
  • Hamasaki T, Sugimoto T, Evans SR, Sozu T. Sample size determination in clinical trials with two time-to-event outcomes. DIA/FDA Statistics 2016 Forum, Bethesda, MD, USA, April 25-27, 2016.

最終更新日 2017年07月25日

ページ上部へ